Detection of novel amplicons in prostate cancer by comprehensive genomic profiling of prostate cancer cell lines using oligonucleotide-based arrayCGH

PLoS ONE

Volumn 2, Issue 8, 2007, Pages

  Kamradt, Joern ^a   Jung, Volker ^a   Wahrheit, Kerstin ^a   Tolosi, Laura ^b   Rahnenfuehrer, Joerg ^c   Schilling, Martin ^d   Walker, Robert ^e   Davis, Sean ^e   Stoeckle, Michael ^a   Meltzer, Paul ^e   Wullich, Bernd ^a  

^a SAARLAND UNIVERSITY   (Germany)

^b MAX PLANCK INSTITUTE FOR INFORMATICS   (Germany)

^c TU DORTMUND UNIVERSITY   (Germany)

^d SAARLAND UNIVERSITY   (Germany)

^e NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DYNACTIN; INTERLEUKIN 11 RECEPTOR; OLIGONUCLEOTIDE;

AMPLICON; ARTICLE; BACTERIAL ARTIFICIAL CHROMOSOME; CANCER CELL CULTURE; CARCINOGENESIS; CENTROMERE; COMPARATIVE GENOMIC HYBRIDIZATION; CONTROLLED STUDY; DNA MICROARRAY; FLUORESCENCE IN SITU HYBRIDIZATION; GENE AMPLIFICATION; GENE DELETION; GENE IDENTIFICATION; GENE MUTATION; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; PROSTATE CANCER; REAL TIME POLYMERASE CHAIN REACTION; TELOMERE;

CELL LINE, TUMOR; CHROMOSOMES, HUMAN; COMPARATIVE GENOMIC HYBRIDIZATION; DNA COPY NUMBER VARIATIONS; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; GENETIC PREDISPOSITION TO DISEASE; GENOME, HUMAN; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; MALE; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PROSTATIC NEOPLASMS;

EID: 40749090707     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0000769     Document Type: Article

References (33)

1. Albertson DG, Collins C, McCormick F, Gray JW (2003) Chromosome aberrations in solid tumors. Nat Genet 34: 369-376.
2. Kallioniemi A, Kallioniemi OP, Sudar D, Rutovitz D, Gray JW, et al. (1992) Comparative genomic hybridization for molecular cytogenetic analysis of solid tumors Science 258: 818-821.
3. Sattler HP, Rohde V, Bonkhoff H, Zwergel T, Wullich B (1999) Comparative genomic hybridization reveals DNA copy number gains to frequently occur in human prostate cancer. Prostate 39: 79-86.
4. Lensch R, Goetz C, Andres C, Bex A, Lehmann J, et al. (2002) Comprehensive genotypic analysis of human prostate cancer cell lines and sublines derived from metastases after orthotopic implantation in nude mice. Int J Oncol 21: 695-706.
5. Strohmeyer DM, Berger AP, Moore DH 2nd, Bartsch G, Klocker H, et al. (2004) Genetic aberrations in prostate carcinoma detected by comparative genomic hybridization and microsatellite analysis: association with progression and angiogenesis. Prostate 59: 43-58.
6. Jung V, Kindich R, Kamradt J, Jung M, Muller M, et al. (2006) Genomic and expression analysis of the 3q25-q26 amplification unit reveals TLOC1/SEC62 as a probable target gene in prostate cancer. Mol Cancer Res 4: 169-176.
7. Rahnenfuehrer J, Beerenwinkel N, Schulz WA, Hartmann C, von Deimling A, et al. (2005) Estimating cancer survival and clinical outcome based on genetic tumor progression scores. Bioinformatics 21: 2438-2446.
8. Solinas-Toldo S, Lampel S, Stilgenhauer S, Nickolenko J, Benner A, et al. (1997) Matrix-based comparative genomic hybridization: biochips to screen for genomic imbalances. Genes Chromosomes Cancer 20: 399-407.
9. Pollack JR, Perou CM, Alizadeh AA, Eisen MB, Pergamenschikov A, et al. (1999) Genome-wide analysis of DNA copy-number changes using cDNA microarrays. Nat Genet 23: 41-46.
10. Pinkel D, Segraves R, Sudar D, Clark S, Poole I, et al. (1998) High resolution analysis of DNA copy number variation using comparative genomic hybridization to microarrays. Nat Genet 20: 207-111.
11. Brennan C, Zhang Y, Leo C, Feng B, Cauwels C, et al. (2004) High-resolution global profiling of genomic alterations with longoligonucleotide microarray. Cancer Res 64: 4744-4748.
12. Wolf M, Mousses S, Hautaniemi S, Karhu R, Huusko P, et al. (2004) High-resolution analysis of gene copy number alterations in human prostate cancer using CGH on cDNA microarrays: impact of copy number on gene expression. Neoplasia 6: 240-247.
13. Saramaki OR, Porkka KP, Vessella RL, Visakorpi T (2006) Genetic aberrations in prostate cancer by microarray analysis. Int J Cancer 119: 1322-1329.
14. Barrett MT, Scheffer A, Ben-Dor A, Sampas N, Lipson D, et al. (2004) Comparative genomic hybridization using oligonucleotide microarrays and total genomic DNA. Proc NatlAcadSciUSA 101: 17765-17770.
15. Clark J, Edwards S, Feber A, Flohr P, John M, et al. (2003) Genome-wide screening for complete genetic loss in prostate cancer by comparative hybridization onto cDNA microarrays. Oncogene 22: 1247-1252.
16. Paris PL, Albertson DG, Alers JC, Andaya A, Carroll P, et al. (2003) High-resolution analysis of paraffin-embedded and formalin-fixed prostate tumors using comparative genomic hybridization to genomic microarrays. Am J Pathol 162: 763-770.
17. Dekken van H, Paris PL, Albertson DG, Alers JC, Andaya A, et al. (2004) Evaluation of genetic patterns in different tumor areas of intermediate-grade prostatic adenocarcinomas by high-resolution genomic array analysis. Genes Chromosomes Cancer 39: 249-256.
18. Hermans KG, van Alewijk DC, Veltman JA, van Weerden W, van Kessel AG, et al. (2004) Loss of a small region around the PTEN locus is a major chromosome 10 alteration in prostate cancer xenografts and cell lines. Genes Chromosomes Cancer 39: 171-184.
19. Yano S, Matsuyama H, Matsuda Y, Matsumoto H, Yoshihiro S, et al. (2004) Accuracy of an array comparative genomic hybridization (CGH) technique in detecting DNA copy number aberrations: comparison with conventional CGH and loss of heterozygosity analysis in prostate cancer. Cancer Genet Cytogenet 150: 122-127.
20. Zhao H, Kim Y, Wang P, Lapointe J, Tibshirani R, et al. (2005) Genome-wide characterization of gene expression variations and DNA copy number changes in prostate cancer cell lines. Prostate 63: 187-197.
21. Rembrink K, Romijn JC, van der Kwast TH, Ruebben H, Schroeder FH (1997) Orthotopic implantation of human prostate cancer cell lines: a clinically relevant animal model for metastatic prostate cancer. Prostate 31: 168-174.
22. Bex A, Wullich B, Endris V, Otto T, Rembrink K, et al. (2001) Comparison of the malignant phenotype and genotype of the human androgen-independent cell line DU 145 and a subline derived from metastasis after orthotopic implantation in nude mice. Cancer Genet Cytogenet 124: 98-104.
23. Chen Y, Dougherty ER, Bittner ML (1997) Ratio-based decisions and the quantitative analysis of cDNA microarray images. J. Biomed Optics 2: 364-374.
24. Gentleman RC, Carey VJ, Bates DM, Bolstad B, Dettling M, et al. (2004) Bioconductor: open software development for computational biology and bioinformatics. Genome Biol 5: R80.
25. Hupé P, Stransky N, Thiery JP, Radvanyi F, Barillot E (2004) Analysis of array CGH data: from signal ratio to gain and loss of DNA regions. Bioinformatics 20: 3413-3422.
26. Jung V, Romeike BFM, Henn W, Feiden W, Moringlane JR, et al. (1999) Evidence of focal genetic microheterogeneity in glioblastoma multiforme by area-specific CGH on microdissected tumor cells. J Neuropathol Exp Neurol 58: 993-999.
27. Kindich R, Florl AR, Jung V, Engers R, Mueller M, et al. (2005) Application of a modified real time PCR technique for relative gene copy number quantification to the determination of the relationship between NKX3.1 loss and MYC gain in prostate cancer. Clin Chem 51: 649-652.
28. Hosono S, Faruqi AF, Dean FB, Du Y, Sun Z, et al. (2003) Unbiased whole-genome amplification directly from clinical samples. Genome Res 13: 954-964.
29. Campbell CL, Jiang Z, Savarese DM, Savarese TM (2001) Increased expression of the interleukin-11 receptor and evidence of STAT3 activation in prostate carcinoma. Am J Pathol 158: 25-32.
30. Zurita AJ, Troncoso P, Cardo-Vila M, Logothetis CJ, Pasqualini R, et al. (2004) Combinatorial screenings in patients: the interleukin-11 receptor alpha as a candidate target in the progression of human prostate cancer. Cancer Res 64: 435-439.
31. Kishimoto T, Akira S, Narazaki M, Taga T (1995) Interleukin-6 family of cytokines and gp130. Blood 86: 1243-1254.
32. Gan L, Zhang L, Hu J, Li F, Shao Y, et al. (2005) Down-regulation of signal transducer and activator of transcription 3 expression using vector-based small interfering RNAs suppresses growth of human prostate tumor in vivo. Clin Cancer Res 11: 6333-6341.
33. Edwards J, Bartlett JM (2005) The androgen receptor and signal-transduction pathways in hormone-refractory prostate cancer. Part 1: Modifications to the androgen receptor Androgen-receptor cofactors and bypass pathways. BJU Int 95: 1320-1326.